Abstract Within a double-blind, cross-above trial, triazolam (0.25 mg) was tested from flunitrazepam (one mg) in the typical midwinter sleeplessness that's generally viewed between in any other case healthful men and women in Northern Norway. Every drug was presented for five evenings, in random purchase, having a 5-night placebo time period in bet